By John Mercado Most people approach their skincare routine as a once-daily habit. The clinical case for twice-daily application of active serums is stronger than the beauty industry usually communicates, and it comes down to pharmacokinetics as much as preference.
Encapsulated actives release over a defined window of time. For 1% encapsulated vitamin A, that window is approximately 8 to 12 hours. A twice-daily application maintains a consistent level of active in the epidermis across the full day rather than a single-dose spike followed by a trough. The difference in cumulative exposure over weeks and months is significant.
For actives that work progressively, like vitamin A and vitamin B3, consistency of exposure determines outcomes. Skin does not transform in response to occasional application of a concentrated active. It responds to sustained, low-level signalling that accumulates over time. Twice-daily use of a well-formulated serum is the most efficient way to deliver that sustained signal.
The practical objection is usually layering. A twice-daily routine that requires five steps morning and evening becomes difficult to maintain. This is where blend-and-not-layer formulation philosophy changes the calculation. A single serum containing 33 actives at clinically tested doses, applied in ten seconds morning and evening, is more likely to be sustained than a complex multi-product routine applied inconsistently.
Rejuvaus was designed around this principle. The Clarify and Renew Serum delivers 15% encapsulated pore-clearing BHA in a once-daily format that can be paired with the ABC Serum for a combined 56 actives across six correction categories. Details at au.rejuvaus.com/products/clarifying-serum
The twice-daily habit is not demanding when the products are designed for it. Ten seconds, morning and evening, is a manageable commitment. The encapsulation technology is what makes that commitment clinically worthwhile.